Warning letter
Beacon Hill Medical Pharmacy, P.C.: warning letter of Sep 24, 2014
FDA warning letter 431730 · Detroit District Office
Key facts
| Reference number | 431730 |
|---|---|
| Company | Beacon Hill Medical Pharmacy, P.C. |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Sep 24, 2014 |
| Posted date | Oct 14, 2014 |
| Issuing office | Detroit District Office |
| Product type | Drugs |
| CFR sections cited | 210.1(b), 201.115, 210, 211, 200.10(b), 211.28(a), 211.42(c)(10)(iii), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.113(b), 211.166(a), 211.167(a) |
| Inspection city | Southfield |
| Inspection ZIP | 48076 |
| Inspection start date | Jul 1, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: